TRAF2 is Upregulated in Relapsing-Remitting Multiple Sclerosis
Authors:
- Reinhard ReußRRReinhard Reuß
- Andreas MirauAMAndreas Mirau
- Marta MistarzMMMarta Mistarz
- Jörg KrausJKJörg Kraus
- Rolf-Hasso BödekerRBRolf-Hasso Bödeker
- Patrick OschmannPOPatrick Oschmann
- 1 April 2013
- journal article
- research article
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 20 (3) , 177-183
Abstract
Objective: To elucidate the role of tumor necrosis factor (TNF) receptor signal transduction in multiple sclerosis (MS). Methods: We performed a cross-sectional analysis of the gene expression of TRAF2 (TNF receptor-associated factor 2) and RIP (receptor-interacting protein) in peripheral blood leukocytes of 23 relapsing-remitting (RR), 19 secondary progressive (SP) and 12 primary progressive (PP) MS patients as well as of 29 healthy controls by quantitative RT-PCR. Additionally, we monitored a subgroup of 15 RRMS patients longitudinally every 3 months over a 9-month time period. Results: TRAF2 expression was significantly elevated in RRMS patients compared to the other disease courses (p < 0.005, respectively) and the control group (p < 0.009). RIP expression was significantly elevated in the patient groups compared to the healthy group (phealthy-RR < 0.002; phealthy-PP < 0.003; phealthy-SP < 0.06). Neither variable changed over the 9-month time course. Conclusion: TRAF2 and RIP1 elevation in leukocytes might be interpreted as the molecular equivalent of an elevated general inflammatory activity in MS patients compared to healthy control persons. TRAF2 elevation in RRMS reinforces the concept that different pathophysiological and immunological processes sustain RRMS and SPMS or PPMS.Keywords
This publication has 26 references indexed in Scilit:
- The relation between inflammation and neurodegeneration in multiple sclerosis brainsBrain, 2009
- Interferon β-1a Induces Tumor Necrosis Factor Receptor 1 but Decreases Tumor Necrosis Factor Receptor 2 Leukocyte mRNA Levels in Relapsing-Remitting Multiple SclerosisNeuroimmunomodulation, 2009
- Muscle precursor cells isolated from aged rats exhibit an increased tumor necrosis factor‐α responseAging Cell, 2009
- Nitric Oxide and TNFα Effects in Experimental Autoimmune Encephalomyelitis DemyelinationNeuroimmunomodulation, 2007
- Decreased expressions of the TNF-alpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosusClinical Rheumatology, 2007
- Compartmentalization of TNF Receptor 1 SignalingImmunity, 2004
- TNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling ComplexImmunity, 1996
- A novel domain within the 55 kd TNF receptor signals cell deathCell, 1993
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983